1)Brougham MF, Wallace WH:Subfertility in children and young people treated for solid and haematological malignancies. British J of Haematolgy 131:143-155, 1995
2)Donnez J, Martinez-Madrid B, Jadoul P, et al:Ovarian tissue cryopreservation and transplantation:a review. Hum Reprod Update 12:519-535, 2006
3)Meirow D, Levron J, Eldar-Geva T, et al:Monitoring the ovaries after autotransplantation of cryopreserved ovarian tissue:endocrine studies, in vitro fertilization cycles, and live birth. Fertil Steril 87:418 e7-e15, 2005
4)Rosendahl M, Loft A, Byskov AG, et al:Biochemical pregnancy after fertilization of an oocyte aspirated from a heterotopic autotransplant of cryopreserved ovarian tissue:case report. Hum Reprod 21:2006-2009, 2006
5)Donnez J, Silber S, Andersen CY, et al:Children born after autotransplantation of cryopreserved ovarian tissue. A review of 13 live births:Ann Med Jan 13(Epub), 2011
6)von Wolff M, Donnez J, Hovatta O, et al:Cryopreservation and autotransplantation of human ovarian tissue prior to cytotoxic therapy--a technique in its infancy but already successful in fertility preservation. Eur J Cancer 45:1547-1553, 2009
7)Ghumman S:Step by Step Ovulation Induction. Anshan Ltd, Kent, United Kingdom. Page 135, 2006
8)S. Muttukrishna, H. McGarrigle, et al:Antral follicle count, anti-Mullerian hormone and inhibin B:predictorsw of ovarian response in assisted reproductive technology? BJOG(An International Journal of Obstetrics and Gynaecology)112:1384-1390, 2005
9)Antonio La Marca, Mariangela Pati, et al:Serum anti-müllerian hormone levels in women with secondary amenorrhea. Fertility and Sterility 85:1547-1549, 2006
10)DN Lekamge, M. Barry, et al:Anti-Müllerian hormone as a predictor of IVF Outcome. Reproductive Bio Medicine Online;602-610, 2007
11)Fréour T, Mirallié S, et al:Measurement of serum anti-Müllerian hormone by Beckman Coulter ELISA and DSL ELISA:comparison and relevance in assisted reproduction technology(ART). Clin Chim Acta 375:162-164, 2007
12)Joop SE Laven, Annemarie G.M.C:Anti-Mullerian Hormone Serum Concentraitons in Normoovulatory and Anovulatory Women of Reproductive Age. the Journal of Clinical Endocrinology & Metabolism 89:318-323, 2004
13)Vital VS, Tellez S, Alvaarado I, et al:Clinical histologic correlation in reproductive pathology. Obstet Gynecol 95:S83, 2000
14)杉下陽堂,園田桃代,石塚文平,他:Transvaginal Hydro Laparoscopy(THL)を用いたPremature ovarian failure(POF)の評価.日本受精着床学会雑誌26:255-258,2009
15)鈴木 直,高江正道,五十嵐豪,他:卵巣組織凍結保存,自家移植の現状.臨婦産63:1373-1377,2009
16)Igarashi S, Suzuki N, Hashimoto S, et al:Heterotopic autotransplantation of ovarian cortex in cynomolgus monkeys. Hum Cell 23:26-34, 2010
17)Hashimoto S, Suzuki N, Yamanaka M, et al:Effects of vitrification solutions and equilibration times on the morphology of cynomolgus ovarian tissues. Reprod Biomed Online 501-509, 2010
18)Kyono K, Doshida M, Toya M, et al:Potential indications for ovarian autotransplantation based on the analysis of 5,571 autopsy findings of females under the age of 40 in Japan. Fertil Steril 93:2429-2430, 2010
19)Sancez M, Rosello-Sastre E, Teruel J, et al:Incidence of micrometastasses in women with breast cancer requesting ovarian cryopreservation to preserve fertility. Abs O-108, i43, 23rd, Annual Meeting of the ESHURE, Lyon, France
20)Elizur SE, Chian RC, Pinear CA, et al:Fertility preservation treatment for young women with autoimmune diseases facing treatment with gonadotoxic agents. Rheumatology 47:1506-1509, 2008
21)Manger K, Wildt L, Kalden JR, et al:Prevention og gonadal toxicity and preservation of gonadal function and fertility in young women with systematic lupus erythematosus treated by cyclophosphamide. The PREGO-Study. Autoimmunity Reviews 5:269-272, 2006